Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis. (2019)
Attributed to:
A novel vaccine for broad protection against meningococcal disease: progression to phase I clinical trial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-43139-0
PubMed Identifier: 31048732
Publication URI: http://europepmc.org/abstract/MED/31048732
Type: Journal Article/Review
Volume: 9
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322